Log In
Print
BCIQ
Print
Print this Print this
 

Celsentri, Selzentry (maraviroc, Celsentri/Selzentry)

Also known as: UK-427,857

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionCC chemokine receptor 5 (CCR5) antagonist
Molecular Target CC chemokine receptor 5 (CCR5) (CD195)
Mechanism of ActionCC chemokine receptor 5 (CCR5) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHIV / AIDS
Indication DetailsPre-exposure prophylaxis (PrEP) to reduce risk of HIV-1 infection in uninfected adults; Treat HIV infection in antiretroviral-naïve patients; Treat HIV infection in treatment-experienced patients; Treat HIV infection/AIDS
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today